Inventor · disambiguated record
Joseph Bolen
Also filed as: BOLEN JOSEPH · BOLEN JOSEPH B · BOLEN JOSEPH BEENE
19 granted patents·21 pending applications·187 citations·filing 1993–2024
95Inventor score
Files withUNIV NEW YORK12VOR BIOPHARMA INC11MODERNATX INC9PURETECH LYT INC4MODERNA THERAPEUTICS INC2
Top patents by PatentIndex Score
40 records- 0198US10023626B2Polynucleotides encoding immune modulating polypeptidesMODERNATX INC·Filed 2014·Granted Jul 17, 2018·46 cites·17 claims
- 0297US9925277B2Polynucleotide compositions containing amino acidsMODERNATX INC·Filed 2014·Granted Mar 27, 2018·26 cites·14 claims
- 0396US11571445B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2021·Granted Feb 7, 2023·4 cites·21 claims
- 0496US11559551B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2021·Granted Jan 24, 2023·5 cites·18 claims
- 0596US11382932B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2021·Granted Jul 12, 2022·4 cites·25 claims
- 0696US10925902B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2019·Granted Feb 23, 2021·8 cites·19 claims
- 0796US10323076B2Polynucleotides encoding low density lipoprotein receptorMODERNATX INC·Filed 2014·Granted Jun 18, 2019·53 cites·13 claims
- 0895US11903973B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2021·Granted Feb 20, 2024·3 cites·31 claims
- 0995US11629191B2Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2022·Granted Apr 18, 2023·4 cites·17 claims
- 1095US11464807B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2021·Granted Oct 11, 2022·5 cites·22 claims
- 1193US11389485B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2019·Granted Jul 19, 2022·4 cites·20 claims
- 1293US10344091B2Anti-Galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2018·Granted Jul 9, 2019·9 cites·30 claims
- 1391US10815291B2Polynucleotides encoding immune modulating polypeptidesMODERNATX INC·Filed 2018·Granted Oct 27, 2020·3 cites·15 claims
- 1491US10450374B2Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2019·Granted Oct 22, 2019·5 cites·20 claims
- 1585US11414492B2Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2019·Granted Aug 16, 2022·2 cites·30 claims
- 1681US11975029B2Compositions and methods for inhibition of lineage specific proteinsVOR BIOPHARMA INC·Filed 2018·Granted May 7, 2024·1 cites·19 claims
- 1781US2023053285A1Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1875US2024350550A1Compositions and methods for inhibition of lineage specific proteinsVOR BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1974US2025333506A1Antibodies specific to delta 1 chain of t cell receptorUNIV NEW YORK·Filed 2024·Application pending·0 cites
- 2073US12251403B2Genetically engineered hematopoietic stem cells and uses thereofVOR BIOPHARMA INC·Filed 2020·Granted Mar 18, 2025·0 cites·18 claims
- 2166US2021269506A1Polynucleotides encoding immune modulating polypeptidesMODERNATX INC·Filed 2020·Application pending·0 cites
- 2263US2022178930A1Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2020·Application pending·0 cites
- 2363US2022185896A1Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2020·Application pending·0 cites
- 2462US12084500B2Antibodies specific to delta 1 chain of T cell receptorUNIV NEW YORK·Filed 2020·Granted Sep 10, 2024·0 cites·32 claims
- 2561US2016136236A1Compositions and Methods of Altering Cholesterol LevelsMODERNA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2659US2018214579A1Polynucleotide compositions containing amino acidsMODERNATX INC·Filed 2018·Application pending·0 cites
- 2757US2019248864A1Polynucleotides encoding low density lipoprotein receptorMODERNATX INC·Filed 2019·Application pending·0 cites
- 2857US2024043543A1Anti-galectin-9 antibodies and therapeutic uses thereofUNIV NEW YORK·Filed 2021·Application pending·0 cites
- 2957US2024109968A1Anti-galectin-9 antibodies and therapeutic uses thereofUNIV NEW YORK·Filed 2021·Application pending·0 cites
- 3057US2022204629A1Anti-galectin-9 antibodies and uses thereofUNIV NEW YORK·Filed 2020·Application pending·0 cites
- 3154US2024287195A1Anti-galectin-9 antibodies and uses thereof in the treatment of ocular melanomaPURETECH LYT INC·Filed 2021·Application pending·0 cites
- 3251US2022332832A1Combined cancer therapy of anti-galectin-9 antibodies and chemotherapeuticsUNIV NEW YORK·Filed 2020·Application pending·0 cites
- 3351US2021177757A1Exosomes for delivery of therapeutic agentsPURETECH LYT INC·Filed 2020·Application pending·0 cites
- 3450US2023157955A1Vesicle compositions for oral deliveryPURETECH LYT INC·Filed 2021·Application pending·0 cites
- 3548US2018193270A1Exosomes for delivery of therapeutic agentsPureTech Health LLC·Filed 2017·Application pending·0 cites
- 3648US2021290538A1Milk vesicles for use in delivering biological agentsPURETECH LYT INC·Filed 2019·Application pending·0 cites
- 3740US2017002060A1Polynucleotides for the in vivo production of antibodiesMODERNA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3840US2021206818A1Messenger ribonucleic acids for the production of intracellular binding polypeptides and methods of use thereofMODERNATX INC·Filed 2017·Application pending·0 cites
- 3934US2019119357A1Messenger ribonucleic acids for the production of intracellular binding polypeptides and methods of use thereofMODERNATX INC·Filed 2016·Application pending·0 cites
- 4033US6303369B1Protein expression systemFiled 1993·Granted Oct 16, 2001·5 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Joseph Bolen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →